Phase 2b Controlled Trial of M72/AS01E Vaccine to Prevent Tuberculosis
Van Der Meeren, Olivier, Hatherill, Mark, Nduba, Videlis, Wilkinson, Robert J, Muyoyeta, Monde, Van Brakel, Elana, Ayles, Helen M, Henostroza, German, Thienemann, Friedrich, Scriba, Thomas J, Diacon, Andreas, Blatner, Gretta L, Demoitié, Marie-Ange, Tameris, Michele, Malahleha, Mookho, Innes, James C, Hellström, Elizabeth, Martinson, Neil, Singh, Tina, Akite, Elaine J, Khatoon Azam, Aisha, Bollaerts, Anne, Ginsberg, Ann M, Evans, Thomas G, Gillard, Paul, Tait, Dereck R
Published in The New England journal of medicine (25.10.2018)
Published in The New England journal of medicine (25.10.2018)
Get full text
Journal Article
Phase 2b Controlled Trial of M72/AS01 E Vaccine to Prevent Tuberculosis
Van Der Meeren, Olivier, Hatherill, Mark, Nduba, Videlis, Wilkinson, Robert J, Muyoyeta, Monde, Van Brakel, Elana, Ayles, Helen M, Henostroza, German, Thienemann, Friedrich, Scriba, Thomas J, Diacon, Andreas, Blatner, Gretta L, Demoitié, Marie-Ange, Tameris, Michele, Malahleha, Mookho, Innes, James C, Hellström, Elizabeth, Martinson, Neil, Singh, Tina, Akite, Elaine J, Khatoon Azam, Aisha, Bollaerts, Anne, Ginsberg, Ann M, Evans, Thomas G, Gillard, Paul, Tait, Dereck R
Published in The New England journal of medicine (25.10.2018)
Published in The New England journal of medicine (25.10.2018)
Get full text
Journal Article